等待開盤 06-12 09:30:00 美东时间
0.000
0.00%
The latest announcement is out from Flushing Financial ( ($FFIC) ). Flushing Fi...
06-02 07:24
OceanFirst Financial Corp. completed its merger with Flushing Financial Corporation, creating a regional bank with 71 branches across New Jersey, New York, Long Island, and other major areas. Flushing shareholders received 0.85 shares of OceanFirst stock, and Warburg Pincus invested $225 million. Flushing’s former CEO, John Buran, joined OceanFirst’s board as non-executive chairman. The combined company also pledged $5 million to community organi...
06-01 21:14
Flushing Financial (NASDAQ:FFIC) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.34 by 17.14 percent. This is a 26.09 percent increase over earnings of $0.23 per share
04-29 05:04
OceanFirst Financial (OCFC) and Flushing Financial (FFIC) on Monday said they have received all required regulatory and shareholder approvals to complete their proposed merger. The companies said the ...
04-27 19:59
OceanFirst Financial (NASDAQ:OCFC) held its first-quarter earnings conference c...
04-25 00:34
Flushing Financial Opens New Chatham Square Branch in Manhattan Chinatown Flushing Financial Corporation, parent of Flushing Bank, has expanded its Manhattan presence by opening a new Chatham Square branch at 5 Chatham Square in Chinatown. The bank said the new location underscores its commitment to
03-03 22:00
Flushing Financial (FFIC) declares $0.22/share quarterly dividend, in line with previous. Forward yield 5.51% Payable March 27; for shareholders of record March 13; ex-div March 13. See FFIC Dividend ...
02-25 06:02
Flushing Financial SEVP Thomas Buonaiuto Reports Sale of Common Shares Thomas Buonaiuto, SEVP of Flushing Financial Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies
02-04 03:47
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38